Skip to main content

Advertisement

ADVERTISEMENT

Rosacea News

News
12/01/2016
Patients with rosacea, especially women and people over 50, are at increased risk of new-onset migraine, new findings show.
Patients with rosacea, especially women and people over 50, are at increased risk of new-onset migraine, new findings show.
Patients with rosacea,...
12/01/2016
The Dermatologist
News
10/31/2016
The National Rosacea Society (NRS) has awarded funding for 3 new studies, in addition to continuing support for 2 ongoing studies, as part of its research grants program to increase knowledge and understanding of the causes and other key...
The National Rosacea Society (NRS) has awarded funding for 3 new studies, in addition to continuing support for 2 ongoing studies, as part of its research grants program to increase knowledge and understanding of the causes and other key...
The National Rosacea Society...
10/31/2016
The Dermatologist
News
09/13/2016
Foamix Pharmaceuticals Ltd. reported topline results of its Phase 2 clinical trial of its topical foam FMX103 for the treatment of papulopustular rosacea.
Foamix Pharmaceuticals Ltd. reported topline results of its Phase 2 clinical trial of its topical foam FMX103 for the treatment of papulopustular rosacea.
Foamix Pharmaceuticals Ltd....
09/13/2016
The Dermatologist

Advertisement

News
02/04/2016
Danish researchers have linked the common facial skin disorder rosacea to the most frequent type of primary brain tumor in adults.
Danish researchers have linked the common facial skin disorder rosacea to the most frequent type of primary brain tumor in adults.
Danish researchers have linked...
02/04/2016
The Dermatologist
News
08/25/2015
Azelaic acid foam, 15% (Finacea, Bayer HealthCare) received FDA approval for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. The approval is based on results from 2 pivotal clinical trials...
Azelaic acid foam, 15% (Finacea, Bayer HealthCare) received FDA approval for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. The approval is based on results from 2 pivotal clinical trials...
Azelaic acid foam, 15%...
08/25/2015
The Dermatologist
News
06/26/2014
Results from a small study showed that a topical gel, called TDT 068, improved non-transient erythema in patients with erythematotelangiectatic (subtype 1) rosacea. In the randomized trial of nearly 60 patients, German dermatologists compared...
Results from a small study showed that a topical gel, called TDT 068, improved non-transient erythema in patients with erythematotelangiectatic (subtype 1) rosacea. In the randomized trial of nearly 60 patients, German dermatologists compared...
Results from a small study...
06/26/2014
The Dermatologist

Advertisement

News
06/25/2014
The use of branded acne medications increased in dermatology offices that accepted free drug samples, concluded a study recently published in JAMA Dermatology. The study also found that free samples of acne drugs led to a 2-fold increase in...
The use of branded acne medications increased in dermatology offices that accepted free drug samples, concluded a study recently published in JAMA Dermatology. The study also found that free samples of acne drugs led to a 2-fold increase in...
The use of branded acne...
06/25/2014
The Dermatologist
News
03/31/2011
The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to alert the public to the warning signs of this chronic and conspicuous facial disorder now estimated to affect more than 16 million Americans.
The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to alert the public to the warning signs of this chronic and conspicuous facial disorder now estimated to affect more than 16 million Americans.
The National Rosacea Society...
03/31/2011
The Dermatologist

Advertisement